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collected light signal provides information on the beam 
profile. A first prototype was developed and tested with 2 
MeV protons [1]. On this basis, a fully motorized device was 
designed and built for the Bern medical cyclotron [2], which 
is used for the production of PET radioisotopes and multi-
disciplinary research activities. The 10 cm long and 400 μm 
diameter sensing fiber is connected with a commercial 
optical fiber transporting the signal outside of the bunker. 
Cerium, antimony doped and non-doped sensing silica fibres 
were used, according to the intensity range. The fibres 
operate in vacuum and the signal is read out by a photo diode 
or by a PMT. The read out device, the control of the motor 
and the DAQ are integrated into a single compact apparatus. 
Results: The UniBEaM detector was tested at the Bern 
medical cyclotron delivering beams from a few pA to 150 μA 
[3]. Two beam profiles are reported in Figure 1, taken at 50 
pA and 1 μA, respectively. Due to their higher light yield, Ce 
doped fibres were used for intensities in the pico- and 
nanoampere range. Here the signal is recorded at successive 
steady positions of the fibre by single photon counting. For 
intensities from 100 nA to 1 μA, Sb doped fibres read out by a 
photodiode were used. The fiber is now moved continuously 
and the amplitude of the signal recorded. From 1 nA to 1 μA, 
the output signal was found to be linear with respect to the 
beam intensity. In this range, the position of the beam can 
be measured with a precision of about 0.1 mm, allowing the 
use of the UniBEaM detector for beam dynamics studies [4]. 
At intensities above 1 μA, a non-doped sensing fibre was 
used. Due to the dependence of the light transmission on 
temperature, the beam profile was found to be distorted, 
with a consequent non-linearity of the signal with respect to 
intensity. Nevertheless, the position of the beam can be 
monitored. This is a key feature for radioisotope production, 
especially if a solid target is used. 
Conclusions: The UniBEaM detector is based on the collection 
of the optical signal produced by an ion beam traversing a 
silica fiber. This device was successfully tested at the Bern 
medical cyclotron at intensities ranging from a few pA to 
about 20 μA, opening the way for its use in the production of 
medical radioisotopes and cancer hadrontherapy. Its 
commercialization is underway. 
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Figure 1 – Beam profiles measured at 50 pA (left) and 1 A 
(right). 
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Microbeam Radiation Therapy (MRT) is a novel technique[1]  
using spatially fractionated, intense, highly collimated, 
parallel arrays of X-ray beams generated at 3rd generation 
synchrotron facilities like the ESRF in Grenoble, France. The 
insertion of an adequate multislit collimator[2] produces 
microbeams with a FWHM between 20 and 100 μm with 
separations between 100 and 400 μm to be delivered at an 
extremely high dose rate (up to 20kGy/sec) to best exploit 
the dose volume effect with peak entrance dose values well 
above several hundreds of Gy, demonstrating a very high 
normal tissue tolerance even for the immature tissue [3]. The 
differential effects[4] between normal tissue vasculature and 
tumor vascular networks promote this novel approach and 
questions one of the dogmas in radiation therapy: namely, 
that radiation therapy is aiming at a dose distributions with 
the primary goal to maximize the dose at the target, while 
minimizing the dose to the normal tissue in order to generally 
optimize the treatment in cancer therapy. An overview of 
the most important findings in radiation biology as well as 
achievements in Medical Physics will be summarized 
reflecting the current status of the project. 
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Purpose: Therapeutic irradiation of brain cancers is 
associated with severe cognitive deficits in patients who 
survive long enough after irradiation. Radiotherapy-induced 
brain damage and dementia are associated to deficits in 
hippocampal-dependent mechanisms of learning and memory 
[1]. In preclinical rodent models, synchrotron-generated 
arrays of microbeams have shown unprecedented therapeutic 
effect on aggressive tumors of the central nervous system; 
furthermore microbeams are very well tolerated by normal 
tissues [2,3]. This latter effect is due to a minimal dose 
spreading outside the microbeam path. Recently, we showed 
that irradiation of the sensorimotor cortex of epileptic rats 
with synchrotron-generated microbeams reduces seizures 
without disrupting neurological functions [4]. Here we 
explored the long-term effects of microbeam versus 
broadbeam irradiation on hippocampal neurogenesis.  
Materials/Methods: Two groups of male Wistar rats (175-200 
g, two months of age) were irradiated with 5 or 10 Gy 
broadbeams, 3 groups were irradiated with 9 parallel 
microbeam arrays (75 μm wide, spaced 200 μm center-to-
center; peak entrance dose: 150, 300 or 600 Gy). The control 
group was not irradiated. Eight months later, we assessed 
cognitive functions by the Morris water maze, depressive-like 
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behaviors by the Porsolt forced swim test, and locomotor 
activity and anxiety by the open field test. We also studied 
adult neurogenesis within the hippocampal dentate gyrus by 
using the thymidine analogue BrdU to label replicating stem 
cells. Ten months after irradiation animals were killed and 
brain tissue used for histology and immunohistochemistry.  
Results: Microbeam irradiation did not alter cognitive 
performance. Interestingly, microbeam irradiation (300 Gy) 
significantly reduced the immobility time in the forced swim 
test without affecting locomotor activity as compared to 
control rats and 5-10 Gy irradiated rats. Histological analysis 
showed that microbeam irradiation did not alter the 
cytoarchitecture of the hippocampus with cell death 
observed only along the irradiation pathway. We did not 
observe a reduction of hippocampal neurogenesis, assessed 
by stereological counts of BrdU-positive cells in the dentate 
gyrus of the hippocampus at 10 months after microbeam 
irradiation.  
Conclusions: These data shed light on the biological effects 
of microbeam irradiation on the CNS and may open new 
potential therapeutic strategies in cancer treatment and 
other CNS disorders. 
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Recent clinical results using Stereotactic Radiation Therapy 
(SRT) are very encouraging. Our goal is to investigate 
whether the excellent SRT tumor control data imply that 
there are new tumoricidal mechanisms that determine tumor 
control at high SRT doses – new mechanisms which are not 
present or have little effect at conventional radiotherapeutic 
doses.  
To accomplish this, we investigate whether the standard LQ 
model with heterogeneity can provide as good a description 
of the SRT data as can models with extra terms describing 
unique high-dose tumor control mechanisms. 
We analyzed published TCP data for lung tumors or brain 
metastases from 3000 SRT patients, covering a wide range of 
doses and fraction numbers. We used: (a) a linear-quadratic 
model (including heterogeneity), which assumes the same 
mechanisms at all doses, and (b) alternative models with 
terms describing distinct tumoricidal mechanisms at high 
doses. 
Both for lung and brain data, the LQ model provided a 
significantly better fit over the entire range of treatment 
doses than did any of the models requiring extra terms at 
high doses. Analyzing the data as a function of fractionation 
(1 fraction vs. >1 fraction), there was no significant effect on 
TCP in the lung data, whereas for brain data multi-fraction 
SRT was associated with higher TCP than single-fraction 
treatment. 
This analysis suggests that distinct tumoricidal mechanisms 
do not determine tumor control at high doses/fraction. 
Rather the excellent clinical outcomes seen with SRT are the 
result of the excellent dose distributions which SRT provides, 
which allow delivery of larger doses to the tumor than is 
possible with conventional radiotherapy. Finally, there is 
plausible evidence suggesting that multi-fraction SRT is 
superior to single-dose SRT. 
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Purpose: Image-guided radiotherapy (IGRT) is a technique 
used to optimise RT beam delivery to the tumour by 
following its evolution over time through regular MVCT 
imaging of the treatment area. 
However, its application is limited by clinical concerns over 
the additional dose coming from MVCT imaging, which we 
evaluate in this study. 
Methods: We use the particle transport framework GEANT4[1] 
to model the X-ray beam line from the Tomotherapy Hi-Art 
RT treatment machine at the Addenbrooke's hospital and 
evaluate the imaging dose delivered to the vicinity of the 
tumour. Dose maps are obtained by combining simulations of 
the CT scan using a static beam line with 51 different 
exposition angles. 
All GEANT4 simulations were performed on UK grid 
resources[2] to maximize parallel throughput, using 
anonymised data. 
Results: Simulated beam profiles (PDD, longitudinal and 
lateral) with different MLC beam patterns were compared to 
actual calibration data taken in water tank at Addenbrooke's 
hospital. The agreement between the model and the 
calibration is quantified by the Gamma index[3]. Less than 2% 
of the simulated points exceed Gamma(1%,1mm) 
We also simulated the imaging dose distribution in a prostate 
patient treated in 34 fractions, each fraction starting with 
one MV CT used for image guidance. We used a fan beam 
width of 4 mm with a pitch of 2 mm. The results are shown in 
Figure 1. 
 
 
Figure 1: Normalised imaging dose distributions in Gy for a 
prostate cancer patient, in a transverse plane in the 
treatment region. 
 
The maximum simulated dose is about 1.5 cGy on a single 
MVCT, in agreement with results found in [4] using 
proprietary software. For comparison, the treatment dose in 
the same area goes up to 2 Gy per fraction. 
Conclusions: We have successfully modeled the Megavoltage 
imaging beam line of the Tomotherapy Hi-Art machine used 
for radiotherapy at the Addenbrooke's hospital using Geant 4 
and used it to derive dose maps in the patient. 
Doses were found to be in agreement with other published 
results and negligible with respect to the treatment dose. 
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